Dr. Lamas is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4302 Alton Road, Suite 490
Miami Beach, FL 33140Phone+1 305-674-2998
Summary
- Dr. Gervasio Lamas is a cardiologist in Miami Beach, FL and is affiliated with Mount Sinai Medical Center. He received his medical degree from NYU Grossman School of Medicine, trained at the Brigham and Women's Hospital, and has been in practice over 40 years. He is experienced in general cardiology.
Education & Training
- Brigham and Women's HospitalFellowship, Cardiovascular Disease, 1981 - 1983
- Brigham and Women's HospitalResidency, Internal Medicine, 1978 - 1981
- New York University School of MedicineClass of 1978
Certifications & Licensure
- NY State Medical License 2009 - 2026
- FL State Medical License 1995 - 2025
- MA State Medical License 1980 - 1999
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
- Super Doctor SuperDoctors.com
- Fellow (FACC) American College of Cardiology
Clinical Trials
- Mode Selection Trial in Sinus Node Dysfunction (MOST) Start of enrollment: 1995 Jun 01
- Prolonged Gadolinium Retention After MRI Imaging Start of enrollment: 2017 Jul 01
- Trial to Assess Chelation Therapy 2 Start of enrollment: 2016 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- Response to Tomoyuki Kawada: Blood and urine metal levels in patients with diabetes and cardiovascular disease.Ana Navas-Acien, Daniel B Mark, Kevin Anstrom, Gervasio A Lamas
American Heart Journal. 2024-11-01 - 2 citationsEdetate Disodium-Based Chelation for Patients With a Previous Myocardial Infarction and Diabetes: TACT2 Randomized Clinical Trial.Gervasio A Lamas, Kevin J Anstrom, Ana Navas-Acien, Robin Boineau, Hayley Nemeth
JAMA. 2024-09-10 - 3 citationsBaseline characteristics including blood and urine metal levels in the Trial to Assess Chelation Therapy 2 (TACT2).Ana Navas-Acien, Regina M Santella, Bonnie R Joubert, Zhen Huang, Yuliya Lokhnygina
American Heart Journal. 2024-07-01
Press Mentions
- High Levels of Metals, Particularly Cadmium, Linked to Subclinical CVDSeptember 23rd, 2024
- Lamas Boosts Cardiology at Mount Sinai Medical CenterFebruary 11th, 2022
- Here Are the Three Big Things You Need to Know About Getting Your Blood Pressure DownFebruary 27th, 2021
- Join now to see all
Grant Support
- Trial To Assess Chelation Therapy (TACT)National Heart, Lung, And Blood Institute2007–2012
- Trial To Assess Chelation Therapy (TACT)National Heart, Lung, And Blood Institute2008
- Trial To Assess Chelation Therapy (TACT)National Center For Complementary &Alternative Medicine2002–2004
- Mode Selection Trial In Sinus Node Dysfunction (MOST)National Heart, Lung, And Blood Institute1995–2000
- Scientific Review And Evaluation GrantNational Heart, Lung, And Blood Institute1995
Professional Memberships
- Member
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: